Four types of Bifidobacteria trigger autophagy response in intestinal epithelial cells

Journal of Digestive Diseases

Volumn 15, Issue 11, 2014, Pages 597-605

  Lin, Rong ^a   Jiang, Ye ^a,d   Zhao, Xin Yan ^a   Guan, Yang ^b   Qian, Wei ^a   Fu, Xiao Chao ^c   Ren, Hun Yu ^a   Hou, Xiao Hua ^a  

^a UNION HOSPITAL   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c Wuhan Industry Institute   (China)

^d Second People's Hospital of Chengdu   (China)

Author keywords

Autophagy; Inflammatory bowel diseases; Intestinal epithelial cell; Probiotics

Indexed keywords

AUTOPHAGY PROTEIN 12; AUTOPHAGY PROTEIN 16; AUTOPHAGY PROTEIN 5; CELL PROTEIN; GREEN FLUORESCENT PROTEIN; LIPOPOLYSACCHARIDE; UNCLASSIFIED DRUG; ATG5 PROTEIN, RAT; LC3 PROTEIN, RAT; MICROTUBULE ASSOCIATED PROTEIN; PROBIOTIC AGENT; PROTEIN;

ANIMAL CELL; ARTICLE; AUTOPHAGY; BACTERIAL GROWTH; BIFIDOBACTERIALES; BIFIDOBACTERIUM ADOLESCENTIS; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM LONGUM; BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS; CONTROLLED STUDY; ELECTRIC RESISTANCE; ENTEROPATHOGENIC ESCHERICHIA COLI; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; LONG TERM EXPOSURE; NONHUMAN; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; TIGHT JUNCTION; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING; ANIMAL; BIFIDOBACTERIUM; CELL LINE; EPITHELIUM CELL; ESCHERICHIA COLI; GENETICS; INTESTINE MUCOSA; METABOLISM; MICROBIOLOGY; PHYSIOLOGY;

ANIMALS; AUTOPHAGY; BIFIDOBACTERIUM; CELL LINE; EPITHELIAL CELLS; ESCHERICHIA COLI; INTESTINAL MUCOSA; MICROTUBULE-ASSOCIATED PROTEINS; PROBIOTICS; PROTEINS; RATS;

EID: 84912035345     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/1751-2980.12179     Document Type: Article

References (45)

1. Berry D, Reinisch W. Intestinal microbiota: a source of novel biomarkers in inflammatory bowel diseases? Best Pract Res Clin Gastroenterol 2013; 27: 47-58.
2. Qin J, Li R, Raes J etal. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464: 59-65.
3. De Cruz P, Prideaux L, Wagner J etal. Characterization of the gastrointestinal microbiota in health and inflammatory bowel disease. Inflamm Bowel Dis 2012; 18: 372-390.
4. Sanders ME, Guarner F, Guerrant R etal. An update on the use and investigation of probiotics in health and disease. Gut 2013; 62: 787-796.
5. Leone V, Chang EB, Devkota S. Diet, microbes, and host genetics: the perfect storm in inflammatory bowel diseases. J Gastroenterol 2013; 48: 315-321.
6. Kamada N, Seo SU, Chen GY, Núñez G. Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol 2013; 13: 321-335.
7. Ohman L, Simrén M. Intestinal microbiota and its role in irritable bowel syndrome (IBS). Curr Gastroenterol Rep 2013; 15: 323.
8. Lees CW, Barrett JC, Parkes M, Satsangi J. New IBD genetics: common pathways with other diseases. Gut 2011; 60: 1739-1753.
9. Scharl M, Wojtal KA, Becker HM etal. Protein tyrosine phosphatase nonreceptor type 2 regulates autophagosome formation in human intestinal cells. Inflamm Bowel Dis 2012; 18: 1287-1302.
10. Hampe J, Franke A, Rosenstiel P etal. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 2007; 39: 207-211.
11. Scharl M, Rogler G. Inflammatory bowel disease: dysfunction of autophagy? Dig Dis 2012; 30 Suppl 3: 12-19.
12. Prescott NJ, Fisher SA, Franke A etal. A nonsynonymous SNP in ATG16L1 predisposes to ileal Crohn's disease and is independent of CARD15 and IBD5. Gastroenterology 2007; 132: 1665-1671.
13. Lapaquette P, Glasser AL, Huett A, Xavier RJ, Darfeuille-Michaud A. Crohn's disease-associated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly. Cell Microbiol 2010; 12: 99-113.
14. Kleinnijenhuis J, Oosting M, Plantinga TS etal. Autophagy modulates the Mycobacterium tuberculosis-induced cytokine response. Immunology 2011; 134: 341-348.
15. Vitetta L, Briskey D, Hayes E, Shing C, Peake J. A review of the pharmacobiotic regulation of gastrointestinal inflammation by probiotics, commensal bacteria and prebiotics. Inflammopharmacology 2012; 20: 251-266.
16. Meijer BJ, Dieleman LA. Probiotics in the treatment of human inflammatory bowel diseases: update 2011. J Clin Gastroenterol 2011; 45 Suppl: S139-144.
17. Andrews JM, Tan M. Probiotics in luminal gastroenterology: the current state of play. Intern Med J 2012; 42: 1287-1291.
18. Sultana R, McBain AJ, O'Neill CA. Strain-dependent augmentation of tight-junction barrier function in human primary epidermal keratinocytes by Lactobacillus and Bifidobacterium lysates. Appl Environ Microbiol 2013; 79: 4887-4894.
19. Bermudez-Brito M, Plaza-Díaz J, Muñoz-Quezada S, Gómez-Llorente C, Gil A. Probiotic mechanisms of action. Ann Nutr Metab 2012; 61: 160-174.
20. Konieczna P, Akdis CA, Quigley EM, Shanahan F, O'Mahony L. Portrait of an immunoregulatory Bifidobacterium. Gut Microbes 2012; 3: 261-266.
21. Ylä-Anttila P, Vihinen H, Jokitalo E, Eskelinen EL. Monitoring autophagy by electron microscopy in mammalian cells. Methods Enzymol 2009; 452: 143-164.
22. Yang X, Sheng L, Guan Y, Qian W, Hou X. Synaptic plasticity: the new explanation of visceral hypersensitivity in rats with Trichinella spiralis infection? Dig Dis Sci 2009; 54: 937-946.
23. Mizushima N, Yoshimori T, Levine B. Methods in mammalian autophagy research. Cell 2010; 140: 313-326.
24. Payne CM, Crowley-Skillicorn C, Holubec H etal. Deoxycholate, an endogenous cytotoxin/genotoxin, induces the autophagic stress-survival pathway: implications for colon carcinogenesis. J Toxicol 2009; 2009: 785907.
25. Raju D, Hussey S, Ang M etal. Vacuolating cytotoxin and variants in Atg16L1 that disrupt autophagy promote Helicobacter pylori infection in humans. Gastroenterology 2012; 142: 1160-1171.
26. Dupont N, Jiang S, Pilli M, Ornatowski W, Bhattacharya D, Deretic V. Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1β. EMBO J 2011; 30: 4701-4711.
27. Kimura S, Noda T, Yoshimori T. Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3. Autophagy 2007; 3: 452-460.
28. Neal MD, Sodhi CP, Dyer M etal. A critical role for TLR4 induction of autophagy in the regulation of enterocyte migration and the pathogenesis of necrotizing enterocolitis. J Immunol 2013; 190: 3541-3551.
29. Deretic V, Saitoh T, Akira S. Autophagy in infection, inflammation and immunity. Nat Rev Immunol 2013; 13: 722-737.
30. He C, Klionsky DJ. Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet 2009; 43: 67-93.
31. Patel KK, Stappenbeck TS. Autophagy and intestinal homeostasis. Annu Rev Physiol 2013; 75: 241-262.
32. Huang J, Brumell JH. Autophagy in immunity against intracellular bacteria. Curr Top Microbiol Immunol 2009; 335: 189-215.
33. Lu C, Chen J, Xu HG etal. MIR106B and MIR93 prevent removal of bacteria from epithelial cells by disrupting ATG16L1-mediated autophagy. Gastroenterology 2014; 146: 188-199.
34. Sanz Y, De Palma G. Gut microbiota and probiotics in modulation of epithelium and gut-associated lymphoid tissue function. Int Rev Immunol 2009; 28: 397-413.
35. Cadwell K, Liu JY, Brown SL etal. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 2008; 456: 259-263.
36. Tanida I, Ueno T, Kominami E. LC3 and autophagy. Methods Mol Biol 2008; 445: 77-88.
37. Calderon Toledo C, Arvidsson I, Karpman D. Cross-reactive protection against enterohemorrhagic Escherichia coli infection by enteropathogenic E. coli in a mouse model. Infect Immun 2011; 79: 2224-2233.
38. Savkovic SD, Villanueva J, Turner JR, Matkowskyj KA, Hecht G. Mouse model of enteropathogenic Escherichia coli infection. Infect Immun 2005; 73: 1161-1170.
39. Al-Mamun A, Mily A, Sarker P etal. Treatment with phenylbutyrate in a pre-clinical trial reduces diarrhea due to enteropathogenic Escherichia coli: link to cathelicidin induction. Microbes Infect 2013; 15: 939-950.
40. Thurston TL, Wandel MP, von Muhlinen N, Foeglein A, Randow F. Galectin 8 targets damaged vesicles for autophagy to defend cells against bacterial invasion. Nature 2012; 482: 414-418.
41. Guandalini S. Probiotics for prevention and treatment of diarrhea. J Clin Gastroenterol 2011; 45 Suppl: S149-153.
42. Girardin M, Seidman EG. Indications for the use of probiotics in gastrointestinal diseases. Dig Dis 2011; 29: 574-587.
43. Hosseini A, Nikfar S, Abdollahi M. Probiotics use to treat irritable bowel syndrome. Expert Opin Biol Ther 2012; 12: 1323-1334.
44. Martinez-Lopez N, Singh R. ATGs: scaffolds for MAPK/ERK signaling. Autophagy 2014; 10: 535-537.
45. Meschini S, Condello M, Lista P, Arancia G. Autophagy: molecular mechanisms and their implications for anticancer therapies. Curr Cancer Drug Targets 2011; 11: 357-379.